| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/05/2002 | US20020123107 Nucleotide sequences coding transport protein for use in the diagnosis and treatment of atherosclerosis and nervous system disorders |
| 09/05/2002 | US20020123106 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of nervous system disorders |
| 09/05/2002 | US20020123105 Nucleotide sequences coing lantibiotic for use in the treatment and prevention of infections |
| 09/05/2002 | US20020123104 Human slit polypeptide and polynucleotides encoding same |
| 09/05/2002 | US20020123103 Polypeptide for use in the diagnosis and treatment of genetic disorders |
| 09/05/2002 | US20020123102 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of thyroid defcets |
| 09/05/2002 | US20020123099 Highly expressible genes |
| 09/05/2002 | US20020123098 55063, a novel human NMDA family member and uses thereof |
| 09/05/2002 | US20020123097 Nucleotide sequences coding polypeptides for use in diagnosis and treatment of liver disorders |
| 09/05/2002 | US20020123096 Dopamine receptors and genes |
| 09/05/2002 | US20020123095 Estrogen receptor alpha variants and methods of detection thereof |
| 09/05/2002 | US20020123094 57250, a novel human sugar transporter family member and uses thereof |
| 09/05/2002 | US20020123093 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia |
| 09/05/2002 | US20020123092 Regulatory elements from RP1 gene and uses thereof |
| 09/05/2002 | US20020123091 Composition for use in the diagnosis, prevention and treatment of cardiovascular, endothelial or angiogenic disorders in mammals |
| 09/05/2002 | US20020123083 Nucleic acid endocing growth factor protein |
| 09/05/2002 | US20020123076 Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement |
| 09/05/2002 | US20020123072 Diagnosing spongiform encephalopathies; obtain sample containing preferential protein, incubate with antibody, detect formation of bound complex |
| 09/05/2002 | US20020123067 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 09/05/2002 | US20020123054 Human angiopoietin |
| 09/05/2002 | US20020123049 RNA probe for detecting c-fes mRNA |
| 09/05/2002 | US20020123047 dexB |
| 09/05/2002 | US20020123044 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 09/05/2002 | US20020123042 Detection of loss of the wild-type hubub1 gene |
| 09/05/2002 | US20020123040 Novel guinea pig adenovirus antigen |
| 09/05/2002 | US20020123039 Peptide for use in the prevention and treatment of vial infections |
| 09/05/2002 | US20020122874 Process for preparing peptide nucleic acid probe using polymeric photoacid generator |
| 09/05/2002 | US20020122806 Compositions and methods for in situ and in vivo imaging of cells and tissues |
| 09/05/2002 | US20020122804 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 09/05/2002 | US20020122802 Diagnosis and treatment of malignant neoplasms |
| 09/05/2002 | US20020122797 Monoclonal antibodies; hybridoma cell lines that produce such monoclonal antibodies. |
| 09/05/2002 | US20020122796 Method for Inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand |
| 09/05/2002 | US20020122791 Antigenic CK-18 compounds for therapy and diagnosis and methods for using same |
| 09/05/2002 | US20020122788 Long-term expression of gene products by transforming muscle cells |
| 09/05/2002 | US20020122769 Buffering reagents, chelating agents and stabilizers |
| 09/05/2002 | DE10106835A1 Signaltransduktionsproteine 15B3, 15B3-1 und 15B3-2 und zugrundeliegende DNA-Sequenzen Signal transduction 15B3, 15B3-1 and 15B3-2 and underlying DNA sequences |
| 09/05/2002 | DE10106718A1 Hefestamm von Saccharomyces cerevisiae mit funktioneller Expression eines Glut-Transporters Yeast strain of Saccharomyces cerevisiae with functional expression of Glut-transporter |
| 09/05/2002 | CA2374420A1 Method for producing proteins |
| 09/04/2002 | EP1236803A1 Method of judging flocculating properties of bottom brewer's yeast |
| 09/04/2002 | EP1236800A2 Nucleic acids encoding interferon alpha 2, containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1236799A2 Human nucleic acid sequences derived from breast tumor tissue |
| 09/04/2002 | EP1236798A2 Gene library and method for its production |
| 09/04/2002 | EP1236797A1 63744, a human sugar transporter family member and uses thereof |
| 09/04/2002 | EP1236740A1 Vaccine against HER-2/neu oncogene-associated cancers |
| 09/04/2002 | EP1236739A2 59914 and 59921 Choline transporters and uses therefore |
| 09/04/2002 | EP1236738A1 Internal standard for electrophoretic and chromatographic separation process |
| 09/04/2002 | EP1236473A2 Self-assembling polynucleotide delivery system |
| 09/04/2002 | EP1236124A2 Large scale comparative protein structure modeling |
| 09/04/2002 | EP1235936A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 09/04/2002 | EP1235934A2 Screening method for candidate drugs |
| 09/04/2002 | EP1235933A2 Mammalian toxicological response markers |
| 09/04/2002 | EP1235920A2 Down-regulation and silencing of allergen genes in transgenic peanut seeds |
| 09/04/2002 | EP1235919A1 Recombinant oleosins from cacao and their use as flavoring or emulsifying agents |
| 09/04/2002 | EP1235918A2 Methods for altering the expression of hyphal-specific genes |
| 09/04/2002 | EP1235917A1 Compositions and methods utilizing sequences for controlling nucleic acid expression in yeast |
| 09/04/2002 | EP1235915A2 Transgenic mammals into which a period 1 promoter that confers rhythmical expression has been introduced |
| 09/04/2002 | EP1235914A2 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 09/04/2002 | EP1235910A1 Plant virus particles with exogenous internal eitopes |
| 09/04/2002 | EP1235908A2 Polypeptides and polynucleotides encoding same |
| 09/04/2002 | EP1235907A1 6 human secreted proteins |
| 09/04/2002 | EP1235862A2 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralization antibodies |
| 09/04/2002 | EP1235861A2 Novel steroid-activated nuclear receptors and uses therefor |
| 09/04/2002 | EP1235860A2 G-protein coupled receptors |
| 09/04/2002 | EP1235859A1 New olfactory receptor polypeptides and dna sequences thereof |
| 09/04/2002 | EP1235858A1 Use of the insulin-like-growth factor i isoform mgf for the treatment of neurological disorders |
| 09/04/2002 | EP1235857A1 Transgenic mice expressing fluorescent protein under the control of the nestin promoter |
| 09/04/2002 | EP1235855A2 Methods for monitoring multiple gene expression |
| 09/04/2002 | EP1235854A1 Method of separating prions from biological materials |
| 09/04/2002 | EP1235853A1 Multimeric forms of tnf superfamily ligands |
| 09/04/2002 | EP1235848A1 Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions |
| 09/04/2002 | EP1235847A2 ISOLATION OF FIVE NOVEL GENES CODING FOR NEW Fc RECEPTORS-TYPE MELANOMA INVOLVED IN THE PATHOGENESIS OF LYMPHOMA/MELANOMA |
| 09/04/2002 | EP1235846A1 Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235845A2 24 human secreted proteins |
| 09/04/2002 | EP1235844A1 28 human secreted proteins |
| 09/04/2002 | EP1235843A1 26 human secreted proteins |
| 09/04/2002 | EP1235842A1 Rna interference pathway genes as tools for targeted genetic interference |
| 09/04/2002 | EP1235841A1 Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions |
| 09/04/2002 | EP1235838A1 23 human secreted proteins |
| 09/04/2002 | EP1235837A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 09/04/2002 | EP1235805A2 Immunoassay for neonicotinyl insecticides |
| 09/04/2002 | EP1235596A2 Use of lytic toxins and toxin conjugates |
| 09/04/2002 | EP1235587A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases comprising all-d peptides |
| 09/04/2002 | EP1235586A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 09/04/2002 | EP1235584A2 Virus immunologic determinants |
| 09/04/2002 | EP1235488A1 Product and method for control of obesity |
| 09/04/2002 | EP1235482A1 Novel animal model of alzheimer disease with amyloid plaques and mitochondrial dysfunctions |
| 09/04/2002 | EP1165608A4 A member of the frzb family, frazzled |
| 09/04/2002 | EP1105508B1 Method for purifying biomolecule or protein complexes |
| 09/04/2002 | EP1019458B1 Methods of using ice-controlling molecules |
| 09/04/2002 | EP0999849B1 Use of lbp in the treatment of septicaemia |
| 09/04/2002 | EP0986640B1 Transgenic fish with tissue-specific expression |
| 09/04/2002 | EP0977583B1 Compositions comprising conjugates of stable, active, human ob protein with immunoglobulin fc chain and methods |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/04/2002 | EP0831689B1 Use of the indeterminate gametophyte gene for maize improvement |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0771209B1 Novel peptides |
| 09/04/2002 | EP0764208B1 Bmp-9 compositions |
| 09/04/2002 | EP0755443B1 Tissue-specific enhancer active in prostate |
| 09/04/2002 | EP0711355B1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |